Recent Quotes
My Watchlist
Indicators
Hydroworld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
All News
Headline News
Press Releases
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
BLUE OWL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Blue Owl Capital, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
CEPTON URGENT ALERT: Bragar Eagel & Squire, P.C. Reminds Cepton Stockholders of Upcoming December 8th Lead Plaintiff Deadline
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
MAREX URGENT DEADLINE REMINDER: Bragar Eagel & Squire, P.C. Urges Marex Stockholders to Contact the Firm Before December 8th Deadline
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers MRX
News headline image
ATYR CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds aTyr Investors to Contact the Firm Before December 8th Regarding Their Rights
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers ATYR
News headline image
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages StubHub Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – STUB
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers STUB
News headline image
Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting
From Adaptive Biotechnologies
Via GlobeNewswire
Tickers ADPT
News headline image
Io Therapeutics presents today at the American Society for Hematology Annual Meeting, preclinical studies demonstrating combination treatment with BCMA CAR-T cells plus the company's RXR agonist compound IRX4204 has synergistic efficacy against human
From Io Therapeutics, Inc.
Via GlobeNewswire
News headline image
Arvinas Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab at the 2025 American Society of Hematology Annual Meeting and Exposition
From Arvinas Inc.
Via GlobeNewswire
Tickers ARVN
News headline image
Beam Therapeutics Reports Updated Data from BEACON Phase 1/2 Trial of ristoglogene autogetemcel (risto-cel) Highlighting Durable, Differentiated Profile in Sickle Cell Disease (SCD) at American Society of Hematology (ASH) Annual Meeting
From Beam Therapeutics
Via GlobeNewswire
Tickers BEAM
News headline image
Aptose’s Tuspetinib Triple Drug Therapy Featured at the 2025 ASH Annual Meeting; High Rate of Frontline Clinical Responses Continues Across AML Populations
From Aptose Biosciences, Inc.
Via GlobeNewswire
Tickers APTOF TSX:APS
News headline image
Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
News headline image
Bicara Therapeutics’ Preliminary Phase 1b Expansion Cohort Data Evaluating 750mg of Ficerafusp Alfa Weekly Plus Pembrolizumab Advances Pivotal Study Dose Selection on Track for First Quarter 2026
From Bicara Therapeutics Inc.
Via GlobeNewswire
Tickers BCAX
News headline image
Cardinal Point Wealth Management Releases New 2025 Cross-Border Retirement Guide for High-Net-Worth Families
From Cardinal Point Wealth Management, ULC
Via GlobeNewswire
News headline image
Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients
From Junshi Biosciences
Via GlobeNewswire
News headline image
Cerevance Showcases Positive Phase 2 Results Demonstrating Significant Reduction in OFF Time with Solengepras as an Adjunctive Treatment in Parkinson’s Disease
From Cerevance, Inc.
Via GlobeNewswire
News headline image
Anika Therapeutics, Inc. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors ANIK
From Kirby McInerney LLP
Via GlobeNewswire
Tickers ANIK
News headline image
ORIC® Pharmaceuticals Presents Potential Best-in-Class Profile for Enozertinib with Robust Systemic and CNS Activity in 1L and 2L NSCLC Patients with EGFR Exon 20 Mutations at the ESMO Asia Congress 2025
From ORIC Pharmaceuticals
Via GlobeNewswire
Tickers ORIC
News headline image
JHX DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages James Hardie Industries plc Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – JHX
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers JHX
News headline image
AB Value Partners, L.P. Announces Proposed Settlement of Stockholder Class Action on Behalf of Former Holders of Orbit/FR, Inc. Common Stock - ORFR
From AB Value Partners LP
Via GlobeNewswire
News headline image
ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Synopsys, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SNPS
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers SNPS
News headline image
Webus International Limited Issues Clarification on Previous Announcement Related to Expedia Group
From Webus International Limited
Via GlobeNewswire
Tickers WETO
News headline image
Sprouts Farmers Market, Inc. Stockholders with Large Losses Should Contact Robbins LLP for Information About Leading the SFM Class Action
From Robbins LLP
Via GlobeNewswire
Tickers SFM
News headline image
OWL Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Blue Owl Capital Inc.
From Robbins LLP
Via GlobeNewswire
Tickers OWL
News headline image
BTDR Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Bitdeer Technologies Group
From Robbins LLP
Via GlobeNewswire
Tickers BTDR
News headline image
AVTR DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Avantor, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - AVTR
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers AVTR
News headline image
Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification
From Clearmind Medicine Inc.
Via GlobeNewswire
Tickers CMND
News headline image
Rocket Doctor Announces Granting of RSUs and Options and a Change of CFO
From Rocket Doctor AI Inc.
Via GlobeNewswire
Tickers AIRDF CSE:AIDR
News headline image
CyberloQ Technologies, Inc to Present at the Small Cap Growth Virtual Investor Conference December 9th
From Virtual Investor Conferences; CyberloQ Technologies, Inc
Via GlobeNewswire
Tickers CLOQ
News headline image
Children’s National Hospital welcomes First Lady Melania Trump for holiday visit
From Children's National Hospital
Via GlobeNewswire
News headline image
Global Mofy AI Limited Announces US$4.8 Million Private Placement Financing
From GLOBAL MOFY AI LIMITED
Via GlobeNewswire
Tickers GMM
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.